腹部与盆腔窄窗口CT引导经皮活检钝针入路的安全性与技术成功率
回顾性纳入2015年1月至2018年12月396例连续接受腹部或盆腔CT引导活检或基准标记置入的患者,按穿刺路径宽度分为宽窗口(>15 mm,323例)和窄窗口(≤15 mm,73例,采用钝针入路)。窄窗口组技术成功率100%(73/73),宽窗口组99.7%(322/323);两组临床成功率、即刻及延迟并发症率均无显著差异。结论认为窄窗口(<15 mm)钝针入路CT引导活检与基准标记置入安全且成功。
要点
- 窄窗口定义为穿刺路径与关键结构间宽度≤15 mm,本组占18.5%(73/396)。
- 窄窗口组采用钝针入路,技术成功率100%(73/73),宽窗口组99.7%(322/323)。
- 两组临床成功率、即刻及延迟并发症率均无显著差异。
核心结论
- 窄窗口(<15 mm)钝针入路CT引导下活检与基准标记置入安全且成功。
研究设计与样本
- 回顾性纳入2015年1月至2018年12月连续396例腹部或盆腔CT引导活检或基准标记置入患者(183例女性,平均年龄63±14岁)。
- 根据术中图像将操作分为宽窗口(穿刺路径宽度>15 mm,323例)和窄窗口(≤15 mm,73例)。
- 窄窗口入路采用钝针技术,为本文介入放射团队的首选方法。
诊断标准与关键数值
- 窄窗口组中位穿刺深度97 mm(IQR 82–113 mm),宽窗口组84 mm(IQR 60–106 mm),P=0.0017。
- 技术成功率:窄窗口组100%(73/73),宽窗口组99.7%(322/323)。
- 临床成功率:窄窗口组86.4%(57/66),宽窗口组89.5%(265/296),P=0.46。
- 即刻并发症率:窄窗口组1.3%(1/73),宽窗口组1.2%(4/323),P=0.73。
- 延迟并发症率:窄窗口组1.3%(1/73),宽窗口组0.6%(1/323),P=0.50。
临床应用与阅片要点
- 本研究中心介入放射团队对窄窗口入路首选钝针技术。
- 窄窗口(≤15 mm)钝针入路CT引导活检与基准标记置入可获得与宽窗口入路相似的技术成功率和临床成功率,并发症率无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess success and safety of CT-guided procedures with narrow window access for biopsy.
METHODS: Three hundred ninety-six consecutive patients undergoing abdominal or pelvic CT-guided biopsy or fiducial placement between 01/2015 and 12/2018 were included (183 women, mean age 63 ± 14 years). Procedures were classified into "wide window" (width of the needle path between structures > 15 mm) and "narrow window" (≤ 15 mm) based on intraprocedural images. Clinical information, complications, technical and clinical success, and outcomes were collected. The blunt needle approach is preferred by our interventional radiology team for narrow window access.
RESULTS: There were 323 (81.5%) wide window procedures and 73 (18.5%) narrow window procedures with blunt needle approach. The median depth for the narrow window group was greater (97 mm, interquartile range (IQR) 82-113 mm) compared to the wide window group (84 mm, IQR 60-106 mm); p = 0.0017. Technical success was reached in 100% (73/73) of the narrow window and 99.7% (322/323) of the wide window procedures. There was no difference in clinical success rate between the two groups (narrow: 86.4%, 57/66; wide: 89.5%, 265/296; p = 0.46). There was no difference in immediate complication rate (narrow: 1.3%, 1/73; wide: 1.2%, 4/323; p = 0.73) or delayed complication rate (narrow: 1.3%, 1/73; wide: 0.6%, 1/323; p = 0.50).
CONCLUSION: Narrow window (< 15 mm) access biopsy and fiducial placement with blunt needle approach under CT guidance is safe and successful.
CLINICAL RELEVANCE STATEMENT: CT-guided biopsy and fiducial placement can be performed through narrow window access of less than 15 mm utilizing the blunt-tip technique.
KEY POINTS: • A narrow window for CT-guided abdominal and pelvic biopsies and fiducial placements was considered when width of the needle path between vital structures was ≤ 15 mm. • Seventy-three biopsies and fiducial placements performed through a narrow window with blunt needle approach had a similar rate of technical and clinical success and complications compared to 323 procedures performed through a wide window approach, with traditional approach (> 15 mm). • This study confirmed the safety of the CT-guided percutaneous procedures through < 15 mm window with blunt-tip technique.
引用
- Rigiroli F, Camacho A, Chung A, et al. Safety profile and technical success of narrow window CT-guided percutaneous biopsy with blunt needle approach in the abdomen and pelvis. Eur Radiol. 2023. PMID: 37707549. doi:10.1007/s00330-023-10231-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。